QQQ   307.69 (+2.25%)
AAPL   149.01 (+2.46%)
MSFT   258.88 (+2.43%)
META   181.25 (+18.37%)
GOOGL   106.38 (+5.92%)
AMZN   110.31 (+4.91%)
TSLA   187.73 (+3.48%)
NVDA   211.83 (+1.15%)
NIO   11.99 (-0.91%)
BABA   110.92 (-1.68%)
AMD   85.52 (+1.04%)
T   20.14 (-0.20%)
MU   63.29 (+1.10%)
F   14.07 (+2.03%)
CGC   3.15 (+2.27%)
GE   82.48 (+0.19%)
DIS   109.77 (+0.35%)
AMC   6.10 (+6.83%)
PFE   43.70 (-0.61%)
PYPL   86.28 (+4.06%)
NFLX   360.80 (-0.33%)
QQQ   307.69 (+2.25%)
AAPL   149.01 (+2.46%)
MSFT   258.88 (+2.43%)
META   181.25 (+18.37%)
GOOGL   106.38 (+5.92%)
AMZN   110.31 (+4.91%)
TSLA   187.73 (+3.48%)
NVDA   211.83 (+1.15%)
NIO   11.99 (-0.91%)
BABA   110.92 (-1.68%)
AMD   85.52 (+1.04%)
T   20.14 (-0.20%)
MU   63.29 (+1.10%)
F   14.07 (+2.03%)
CGC   3.15 (+2.27%)
GE   82.48 (+0.19%)
DIS   109.77 (+0.35%)
AMC   6.10 (+6.83%)
PFE   43.70 (-0.61%)
PYPL   86.28 (+4.06%)
NFLX   360.80 (-0.33%)
QQQ   307.69 (+2.25%)
AAPL   149.01 (+2.46%)
MSFT   258.88 (+2.43%)
META   181.25 (+18.37%)
GOOGL   106.38 (+5.92%)
AMZN   110.31 (+4.91%)
TSLA   187.73 (+3.48%)
NVDA   211.83 (+1.15%)
NIO   11.99 (-0.91%)
BABA   110.92 (-1.68%)
AMD   85.52 (+1.04%)
T   20.14 (-0.20%)
MU   63.29 (+1.10%)
F   14.07 (+2.03%)
CGC   3.15 (+2.27%)
GE   82.48 (+0.19%)
DIS   109.77 (+0.35%)
AMC   6.10 (+6.83%)
PFE   43.70 (-0.61%)
PYPL   86.28 (+4.06%)
NFLX   360.80 (-0.33%)
QQQ   307.69 (+2.25%)
AAPL   149.01 (+2.46%)
MSFT   258.88 (+2.43%)
META   181.25 (+18.37%)
GOOGL   106.38 (+5.92%)
AMZN   110.31 (+4.91%)
TSLA   187.73 (+3.48%)
NVDA   211.83 (+1.15%)
NIO   11.99 (-0.91%)
BABA   110.92 (-1.68%)
AMD   85.52 (+1.04%)
T   20.14 (-0.20%)
MU   63.29 (+1.10%)
F   14.07 (+2.03%)
CGC   3.15 (+2.27%)
GE   82.48 (+0.19%)
DIS   109.77 (+0.35%)
AMC   6.10 (+6.83%)
PFE   43.70 (-0.61%)
PYPL   86.28 (+4.06%)
NFLX   360.80 (-0.33%)
OTCMKTS:CCEL

Cryo-Cell International - CCEL Stock Forecast, Price & News

$4.03
-0.01 (-0.25%)
(As of 02/1/2023 12:00 AM ET)
Add
Compare
Today's Range
$4.03
▼
$4.08
50-Day Range
$4.03
▼
$4.89
52-Week Range
$4.00
▼
$9.55
Volume
2,443 shs
Average Volume
6,150 shs
Market Capitalization
$34.34 million
P/E Ratio
26.87
Dividend Yield
N/A
Price Target
$12.00

Cryo-Cell International MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
197.8% Upside
$12.00 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Acquiring Shares
$167,193 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.04 out of 5 stars

See Top Rated MarketRank™ Stocks Here

CCEL stock logo

About Cryo-Cell International (OTCMKTS:CCEL) Stock

Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. It operates through the following segments: Cellular Processing and Cryogenic Storage, and Prepacyte CB. The Cellular Processing and Cryogenic Storage segment focuses on the collection and preservation of umbilical cord blood and tissue stem cells for family use. The Prepacyte CB segment refers to the processing technology used to process umbilical cord blood stem cells. The company was founded in 1989 and is headquartered in Oldsmar, FL.

Receive CCEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cryo-Cell International and its competitors with MarketBeat's FREE daily newsletter.

CCEL Stock News Headlines

November 16, 2022 | benzinga.com
Cryo-Cell International Chairman Trades Company's Stock
October 14, 2022 | finance.yahoo.com
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2022 Financial Results
February 2, 2023 | PressReach (Ad)
Stocks Positioned For The Year
This breakthrough stock has bright future this decade.
August 22, 2022 | finance.yahoo.com
Cord Blood Banking Leader Cryo-Cell Announces Special Cash Dividend
August 18, 2022 | seekingalpha.com
Cryo-Cell International to transfer listing from Nasdaq to NYSE
July 15, 2022 | benzinga.com
Cryo-Cell International (NASDAQ:CCEL), Earnings Estimates, EPS, and Revenue
July 15, 2022 | benzinga.com
Cryo-Cell International (NASDAQ:CCEL), Analyst Ratings, Price Targets, Predictions
July 11, 2022 | finance.yahoo.com
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2022 Financial Results
February 2, 2023 | PressReach (Ad)
Top AI Tech Stock To Watch
Today's stock market news features a Robotics stock with blue sky potential.
June 16, 2022 | bizjournals.com
Logistics firm picks Garner for 240K-square-foot warehouse
April 15, 2022 | bizjournals.com
Why this German company is expanding in Knightdale
April 13, 2022 | seekingalpha.com
CRYO-CELL International GAAP EPS of $0.10, revenue of $7.26M
April 13, 2022 | finance.yahoo.com
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2022 Financial Results
March 23, 2022 | bizjournals.com
Stem cell firm launching Durham facility to attract business
March 18, 2022 | morningstar.com
Cord Blood Banking Leader Cryo-Cell Announces Extravault Biorepository Service | Morningstar
March 16, 2022 | finance.yahoo.com
Cord Blood Banking Leader Cryo-Cell Announces Extravault Biorepository Service
March 9, 2022 | finance.yahoo.com
Cryo-Cell Shares Its 2021 Annual Letter to Shareholders
February 22, 2022 | seekingalpha.com
CRYO-CELL International GAAP EPS of $0.00, revenue of $28.9M
February 22, 2022 | finance.yahoo.com
Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2021
January 15, 2022 | nasdaq.com
Cryo-Cell International, Inc. Common Stock (CCEL)
December 20, 2021 | benzinga.com
How 2020's Hottest IPOs Have Performed In 2021
October 27, 2021 | finance.yahoo.com
Cord Blood Banking Leader Cryo-Cell Announces Its Intent to Advance Clinical Trials
October 15, 2021 | benzinga.com
Cryo-Cell Reports Q3 2021 Revs $7.5M
October 15, 2021 | finance.yahoo.com
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2021 Financial Results
September 21, 2021 | nasdaq.com
Cryo-Cell International, Inc. Shares Near 52-Week Low - Market Mover
September 20, 2021 | finance.yahoo.com
Cryo-Cell International Announces Changes To Its Board of Directors
September 11, 2021 | bizjournals.com
Stem cell firm that partners with Duke University grabs space in Durham
See More Headlines
Receive CCEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cryo-Cell International and its competitors with MarketBeat's FREE daily newsletter.

CCEL Company Calendar

Last Earnings
10/15/2019
Today
2/02/2023
Next Earnings (Estimated)
2/20/2023
Fiscal Year End
11/30/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:CCEL
CUSIP
N/A
CIK
862692
Web
www.cryo-cell.com
Phone
(813) 749-2100
Fax
813-855-4745
Employees
83
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$12.00
High Stock Price Forecast
$12.00
Low Stock Price Forecast
$12.00
Forecasted Upside/Downside
+197.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$0.15
Trailing P/E Ratio
26.87
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$2.08 million
Net Margins
4.34%
Pretax Margin
4.86%
Return on Equity
49.62%
Return on Assets
2.18%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.47
Quick Ratio
0.43

Sales & Book Value

Annual Sales
$28.89 million
Price / Sales
1.19
Cash Flow
$0.41 per share
Price / Cash Flow
9.94
Book Value
$0.49 per share
Price / Book
8.22

Miscellaneous

Outstanding Shares
8,520,000
Free Float
5,640,000
Market Cap
$34.34 million
Optionable
Not Optionable
Beta
0.29

Key Executives

  • David I. PortnoyDavid I. Portnoy
    Chairman & Co-Chief Executive Officer
  • Mark L. Portnoy
    Co-Chief Executive Officer & Director
  • Jill M. Taymans
    Chief Financial Officer & Vice President-Finance
  • Oleg Mikulinsky
    Chief Information Officer
  • Joanne Kurtzberg
    Medical Director

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions













CCEL Stock - Frequently Asked Questions

Should I buy or sell Cryo-Cell International stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cryo-Cell International in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CCEL shares.
View CCEL analyst ratings or view top-rated stocks.

What is Cryo-Cell International's stock price forecast for 2023?

1 analysts have issued 1-year price objectives for Cryo-Cell International's stock. Their CCEL share price forecasts range from $12.00 to $12.00. On average, they anticipate the company's share price to reach $12.00 in the next twelve months. This suggests a possible upside of 197.8% from the stock's current price.
View analysts price targets for CCEL or view top-rated stocks among Wall Street analysts.

How have CCEL shares performed in 2023?

Cryo-Cell International's stock was trading at $4.23 at the beginning of the year. Since then, CCEL stock has decreased by 4.7% and is now trading at $4.03.
View the best growth stocks for 2023 here.

When is Cryo-Cell International's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, February 20th 2023.
View our CCEL earnings forecast.

How were Cryo-Cell International's earnings last quarter?

Cryo-Cell International, Inc. (OTCMKTS:CCEL) posted its quarterly earnings data on Tuesday, October, 15th. The company reported $0.13 earnings per share (EPS) for the quarter. The company earned $8.20 million during the quarter. Cryo-Cell International had a trailing twelve-month return on equity of 49.62% and a net margin of 4.34%.

How often does Cryo-Cell International pay dividends? What is the dividend yield for Cryo-Cell International?

Cryo-Cell International declared a dividend on Monday, August 22nd. Stockholders of record on Friday, September 2nd will be paid a dividend of $0.90 per share on Friday, September 9th. The ex-dividend date is Thursday, September 1st.
Read our dividend analysis for CCEL.

What other stocks do shareholders of Cryo-Cell International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cryo-Cell International investors own include NVIDIA (NVDA), Overstock.com (OSTK), Avid Technology (AVID), Boeing (BA), Enphase Energy (ENPH), OPKO Health (OPK), Riot Platforms (RIOT), Aldeyra Therapeutics (ALDX), Alimera Sciences (ALIM) and Allena Pharmaceuticals (ALNA).

What is Cryo-Cell International's stock symbol?

Cryo-Cell International trades on the OTCMKTS under the ticker symbol "CCEL."

How do I buy shares of Cryo-Cell International?

Shares of CCEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cryo-Cell International's stock price today?

One share of CCEL stock can currently be purchased for approximately $4.03.

How much money does Cryo-Cell International make?

Cryo-Cell International (OTCMKTS:CCEL) has a market capitalization of $34.34 million and generates $28.89 million in revenue each year. The company earns $2.08 million in net income (profit) each year or $0.15 on an earnings per share basis.

How can I contact Cryo-Cell International?

Cryo-Cell International's mailing address is 700 Brooker Creek Boulevard Suite 1800, Oldsmar FL, 34677. The official website for the company is www.cryo-cell.com. The company can be reached via phone at (813) 749-2100, via email at investors@cryo-cell.com, or via fax at 813-855-4745.

This page (OTCMKTS:CCEL) was last updated on 2/2/2023 by MarketBeat.com Staff